Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies

British Journal of Haematology

Volumn 136, Issue 6, 2007, Pages 829-832

  Ying, Jianming ^a   Gao, Zifen ^b   Li, Hongyu ^a   Srivastava, Gopesh ^c   Murray, Paul G ^d   Goh, Hwee Koon ^e   Lim, Chai Yen ^e   Wang, Yajun ^a   Marafioti, Teresa ^f   Mason, David Y ^f   Ambinder, Richard F ^e,g   Chan, Anthony T C ^a   Tao, Qian ^a,e,g,h  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e Johns Hopkins Singapore   (Singapore)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biomarker; Lymphoma; Methylation; PCDH10; Tumour suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; EPIGENETICS; GENE SILENCING; HODGKIN DISEASE; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LEUKEMIA CELL LINE; LYMPH NODE; LYMPHOMA CELL LINE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTOCADHERIN 10 GENE; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE;

BURKITT LYMPHOMA; CADHERINS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEMATOLOGIC NEOPLASMS; HODGKIN DISEASE; HUMANS; LEUKEMIA; LYMPHOMA, LARGE-CELL; LYMPHOMA, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33847379460     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06512.x     Document Type: Article

References (12)

1. Claus, R. & Lubbert, M. (2003) Epigenetic targets in hematopoietic malignancies. Oncogene, 22, 6489-6496.
2. Hoque, M.O., Begum, S., Topaloglu, O., Jeronimo, C., Mambo, E., Westra, W.H., Califano, J.A. & Sidransky, D. (2004) Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Research, 64, 5511-5517.
3. Imoto, I., Izumi, H., Yokoi, S., Hosoda, H., Shibata, T., Hosoda, F., Ohki, M., Hirohashi, S, & Inazawa, J. (2006) Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Research, 66, 4617-4626.
4. Melki, J.R., Vincent, P.C., Brown, R.D., & Clark, S.J. (2000) Hypermethylation of E-cadherin in leukemia. Blood, 95, 3208-3213.
5. Murray, P.G., Qiu, G.H., Fu, L., Waites, E.R., Srivastava, G., Heys, D., Agathanggelou, A., Latif, F., Grundy, R.G., Mann, J.R., Starczynski, J., Crocker, J., Parkes, S.E., Ambinder, R.F., Young, L.S. & Tao, Q. (2004) Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma. Oncogene, 23, 1326-1331.
6. Okazaki, N., Takahashi, N., Kojima, S., Masuho, Y. & Koga, H. (2002) Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis, 23, 1139-1148.
7. Rosenbauer, F., Owens, B.M., Yu, L., Tumang, J.R., Steidl, U., Kutok, J.L., Clayton, L.K., Wagner, K., Scheller, M., Iwasaki, H., Liu, C., Hackanson, B., Akashi, K., Leutz, A., Rothstein, T.L., Plass, C. & Tenen, D.G. (2006) Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nature Genetics, 38, 27-37.
8. Tao, Q., Swinnen, L.J., Yang, J., Srivastava, G., Robertson, K.D., & Ambinder, R.F. (1999) Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. American Journal of Pathology, 155, 619-625.
9. Waha, A., Guntner, S., Huang, T.H., Yan, P.S., Arslan, B., Pietsch, T., Wiestler, O.D. & Waha, A. (2005) Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas. Neoplasia, 7, 193-199.
10. Ying, J., Srivastava, G., Hsieh, W.S., Gao, Z., Murray, P., Liao, S.K., Ambinder, R., & Tao, Q. (2005) The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clinical Cancer Research, 11, 6442-6449.
11. Ying, J., Li, H., Seng, T.J., Langford, C., Srivastava, G., Tsao, S.W., Putti, T., Murray, P., Chan, A.T., & Tao, Q. (2006) Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene, 25, 1070-1080.
12. Yu, L., Liu, C., Vandeusen, J., Becknell, B., Dai, Z., Wu, Y.Z., Raval, A., Liu, T.H., Ding, W., Mao, C., Liu, S., Smith, L.T., Lee, S., Rassenti, L., Marcucci, G., Byrd, J., Caligiuri, M.A. & Plass, C. (2005) Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature Genetics, 37, 265-274.